Aspirin is the cornerstone of the anti-platelet therapy during the acute phase of ST-segment elevation myocardial infarction (STEMI), and it can be administrated orally or intravenously. The oral loading dose of aspirin is well characterized, whereas there are little data on the optimal intravenous (IV) loading dose.
Effect on mortality of different routes of administration and loading dose of aspirin in patients with ST-segment elevation acute myocardial infarction treated with primary angioplasty / Rossi, Rosario; Bagnacani, Alessandra; Sgura, Fabio; Enrique Monopoli, Daniel; Coppi, Francesca; Talarico, Marisa; Rolando, Cristina; Boriani, Giuseppe. - In: CORONARY ARTERY DISEASE. - ISSN 0954-6928. - 31:4(2020), pp. 348-353. [10.1097/MCA.0000000000000840]
Effect on mortality of different routes of administration and loading dose of aspirin in patients with ST-segment elevation acute myocardial infarction treated with primary angioplasty
Rossi, Rosario;Enrique Monopoli, Daniel;Coppi, Francesca;Talarico, Marisa;Rolando, Cristina;Boriani, Giuseppe
2020
Abstract
Aspirin is the cornerstone of the anti-platelet therapy during the acute phase of ST-segment elevation myocardial infarction (STEMI), and it can be administrated orally or intravenously. The oral loading dose of aspirin is well characterized, whereas there are little data on the optimal intravenous (IV) loading dose.File | Dimensione | Formato | |
---|---|---|---|
Effect_on_mortality_of_different_routes_of.98886.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
411.17 kB
Formato
Adobe PDF
|
411.17 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris